Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy

Gene

Volumn 548, Issue 2, 2014, Pages 174-181

  Li, Jian ^a   Liu, Wei Dong ^a   Yang, Zhang Liang ^a   Yuan, Fang ^b   Xu, Lei ^b   Li, Ruo Gu ^b   Yang, Yi Qing ^b  

^a SHANGHAI PUNAN HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Dilated cardiomyopathy; GATA4; Genetics; Reporter gene; Transcriptional factor

Indexed keywords

TRANSCRIPTION FACTOR GATA 4;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXON; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HELA CELL LINE; HUMAN; HUMAN CELL; INTRON; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

DILATED CARDIOMYOPATHY; GATA4; GENETICS; REPORTER GENE; TRANSCRIPTIONAL FACTOR;

ADULT; ANIMALS; CARDIOMYOPATHY, DILATED; CERCOPITHECUS AETHIOPS; COS CELLS; EVOLUTION, MOLECULAR; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS;

EID: 84904967182     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.07.022     Document Type: Article

References (53)

1. Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., Smalls O., Johnson M.C., Watson M.S., Seidman J.G., Seidman C.E., Plowden J., Kugler J.D. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 1999, 104:1567-1573.
2. Brody M.J., Cho E., Mysliwiec M.R., Kim T.G., Carlson C.D., Lee K.H., Lee Y. Lrrc10 is a novel cardiac-specific target gene of Nkx2-5 and GATA4. J. Mol. Cell. Cardiol. 2013, 62:237-246.
3. Chen W., Huo J., Ma A., Bai L., Liu P. A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females. Mol. Cell. Biochem. 2013, 382:307-311.
4. Chugh S.S., Blackshear J.L., Shen W.K., Hammill S.C., Gersh B.J. Epidemiology and natural history of atrial fibrillation: clinical implications. J. Am. Coll. Cardiol. 2001, 37:371-378.
5. Codd M.B., Sugrue D.D., Gersh B.J., Melton L.J. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 1989, 80:564-572.
6. Costa M.W., Guo G., Wolstein O., Vale M., Castro M.L., Wang L., Otway R., Riek P., Cochrane N., Furtado M., Semsarian C., Weintraub R.G., Yeoh T., Hayward C., Keogh A., Macdonald P., Feneley M., Graham R.M., Seidman J.G., Seidman C.E., Rosenthal N., Fatkin D., Harvey R.P. Functional characterization of a novel mutation in NKX2-5 associated with congenital heart disease and adult-onset cardiomyopathy. Circ. Cardiovasc. Genet. 2013, 6:238-247.
7. Elliott P., O'Mahony C., Syrris P., Evans A., Rivera Sorensen C., Sheppard M.N., Carr-White G., Pantazis A., McKenna W.J. Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy. Circ. Cardiovasc. Genet. 2010, 3:314-322.
8. Flack E., Kannankeril P.J. The genetics of dilated cardiomyopathy. Heart Rhythm. 2012, 9:397-398.
9. Garcia-Pavia P., Cobo-Marcos M., Guzzo-Merello G., Gomez-Bueno M., Bornstein B., Lara-Pezzi E., Segovia J., Alonso-Pulpon L. Genetics in dilated cardiomyopathy. Biomark. Med 2013, 7:517-533.
10. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., Rothrock C.R., Eapen R.S., Hirayama-Yamada K., Joo K., Matsuoka R., Cohen J.C., Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
11. Huang W., Meng H., Qiao Y., Pang S., Chen D., Yan B. Two novel and functional DNA sequence variants within an upstream enhancer of the human NKX2-5 gene in ventricular septal defects. Gene 2013, 524:152-155.
12. Jiang J.Q., Shen F.F., Fang W.Y., Liu X., Yang Y.Q. Novel GATA4 mutations in lone atrial fibrillation. Int. J. Mol. Med. 2011, 28:1025-1032.
13. Kärkkäinen S., Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann. Med. 2007, 39:91-107.
14. Kasahara H., Lee B., Schott J.J., Benson D.W., Seidman J.G., Seidman C.E., Izumo S. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest. 2000, 106:299-308.
15. Kikuchi K., Holdway J.E., Werdich A.A., Anderson R.M., Fang Y., Egnaczyk G.F., Evans T., Macrae C.A., Stainier D.Y., Poss K.D. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 2010, 464:601-605.
16. Kirk E.P., Sunde M., Costa M.W., Rankin S.A., Wolstein O., Castro M.L., Butler T.L., Hyun C., Guo G., Otway R., Mackay J.P., Waddell L.B., Cole A.D., Hayward C., Keogh A., Macdonald P., Griffiths L., Fatkin D., Sholler G.F., Zorn A.M., Feneley M.P., Winlaw D.S., Harvey R.P. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am. J. Hum. Genet. 2007, 81:280-291.
17. Kuo C.T., Morrisey E.E., Anandappa R., Sigrist K., Lu M.M., Parmacek M.S., Soudais C., Leiden J.M. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997, 11:1048-1060.
18. Kwon D.H., Eom G.H., Kee H.J., Nam Y.S., Cho Y.K., Kim D.K., Koo J., Kim H.S., Nam G.I., Kim K.K., Lee I.K., Park S.B., Choi H.S., Kook H. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4. J. Mol. Cell. Cardiol. 2013, 65:88-97.
19. Lakdawala N.K., Winterfield J.R., Funke B.H. Dilated cardiomyopathy. Circ. Arrhythm. Electrophysiol. 2013, 6:228-237.
20. Li R.G., Li L., Qiu X.B., Yuan F., Xu L., Li X., Xu Y.J., Jiang W.F., Jiang J.Q., Liu X., Fang W.Y., Zhang M., Peng L.Y., Qu X.K., Yang Y.Q. GATA4 loss-of-function mutation underlies familial dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 2013, 439:591-596.
21. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 2001, 276:30245-30253.
22. Luo R., Li X., Fan X., Yuan W., Wu X. Association of tumor necrosis factor-α gene G-308A polymorphism with dilated cardiomyopathy: a meta-analysis. DNA Cell Biol. 2013, 32:130-137.
23. Lyons I., Parsons L.M., Hartley L., Li R., Andrews J.E., Robb L., Harvey R.P. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 1995, 9:1654-1666.
24. McCulley D.J., Black B.L. Transcription factor pathways and congenital heart disease. Curr. Top. Dev. Biol. 2012, 100:253-277.
25. McNally E.M., Golbus J.R., Puckelwartz M.J. Genetic mutations and mechanisms in dilated cardiomyopathy. J. Clin. Invest. 2013, 123:19-26.
26. Molkentin J.D., Lin Q., Duncan S.A., Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997, 11:1061-1072.
27. Oka T., Maillet M., Watt A.J., Schwartz R.J., Aronow B.J., Duncan S.A., Molkentin J.D. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 2006, 98:837-845.
28. Pankuweit S., Ruppert V., Jónsdóttir T., Müller H.H., Meyer T., On behalf of the German Competence Network of Heart Failure The HLA class II allele DQB1*0309 is associated with dilated cardiomyopathy. Gene 2013, 531:180-183.
29. Pashmforoush M., Lu J.T., Chen H., Amand T.S., Kondo R., Pradervand S., Evans S.M., Clark B., Feramisco J.R., Giles W., Ho S.Y., Benson D.W., Silberbach M., Shou W., Chien K.R. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 2004, 117:373-386.
30. Perrino C., Rockman H.A. GATA4 and the two sides of gene expression reprogramming. Circ. Res. 2006, 98:715-716.
31. Pikkarainen S., Tokola H., Kerkelä R., Ruskoaho H. GATA transcription factors in the developing and adult heart. Cardiovasc. Res. 2004, 63:196-207.
32. Posch M.G., Boldt L.H., Polotzki M., Richter S., Rolf S., Perrot A., Dietz R., Ozcelik C., Haverkamp W. Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation. Eur. J. Med. Genet. 2010, 53:201-203.
33. Prall O.W., Menon M.K., Solloway M.J., Watanabe Y., Zaffran S., Bajolle F., Biben C., McBride J.J., Robertson B.R., Chaulet H., Stennard F.A., Wise N., Schaft D., Wolstein O., Furtado M.B., Shiratori H., Chien K.R., Hamada H., Black B.L., Saga Y., Robertson E.J., Buckingham M.E., Harvey R.P. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 2007, 128:947-959.
34. Pu W.T., Ishiwata T., Juraszek A.L., Ma Q., Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev. Biol. 2004, 275:235-244.
35. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., Conway S.J., Fu J.D., Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
36. Qin X., Xing Q., Ma L., Meng H., Liu Y., Pang S., Yan B. Genetic analysis of an enhancer of the NKX2-5 gene in ventricular septal defects. Gene 2012, 508:106-109.
37. Rajagopal S.K., Ma Q., Obler D., Shen J., Manichaikul A., Tomita-Mitchell A., Boardman K., Briggs C., Garg V., Srivastava D., Goldmuntz E., Broman K.W., Benson D.W., Smoot L.B., Pu W.T. Spectrum of heart disease associated with murine and human GATA4 mutation. J. Mol. Cell. Cardiol. 2007, 43:677-685.
38. Reamon-Buettner S.M., Borlak J. NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum. Mutat. 2010, 31:1185-1194.
39. Ritchie M.D., Rowan S., Kucera G., Stubblefield T., Blair M., Carter S., Roden D.M., Darbar D. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J. Am. Coll. Cardiol. 2012, 60:1173-1181.
40. Ruppert V., Meyer T., Richter A., Maisch B., Pankuweit S. Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy. Gene 2013, 512:206-210. German Competence Network of Heart Failure.
41. Schlesinger J., Schueler M., Grunert M., Fischer J.J., Zhang Q., Krueger T., Lange M., Tönjes M., Dunkel I., Sperling S.R. The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet. 2011, 7:e1001313.
42. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., Maron B.J., Seidman C.E., Seidman J.G. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
43. Song K., Nam Y.J., Luo X., Qi X., Tan W., Huang G.N., Acharya A., Smith C.L., Tallquist M.D., Neilson E.G., Hill J.A., Bassel-Duby R., Olson E.N. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
44. Suzuki Y.J., Evans T.L. Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci. 2004, 74:1829-1838.
45. Wahbi K., Béhin A., Bécane H.M., Leturcq F., Cossée M., Laforêt P., Stojkovic T., Carlier P., Toussaint M., Gaxotte V., Cluzel P., Eymard B., Duboc D. Dilated cardiomyopathy in patients with mutations in anoctamin 5. Int. J. Cardiol. 2013, 168:76-79.
46. Wang J., Sun Y.M., Yang Y.Q. Mutation spectrum of the GATA4 gene in patients with idiopathic atrial fibrillation. Mol. Biol. Rep. 2012, 39:8127-8135.
47. Wang E., Sun S., Qiao B., Duan W., Huang G., An Y., Xu S., Zheng Y., Su Z., Gu X., Jin L., Wang H. Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS One 2013, 8:e62138.
48. Xu X., Zhang L., Liang J. Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats. Mol. Med. Rep. 2013, 8:385-392.
49. Yan H., Yuan W., Velculescu V.E., Vogelstein B., Kinzler K.W. Allelic variation in human gene expression. Science 2002, 297:1143.
50. Yang Y.Q., Wang M.Y., Zhang X.L., Tan H.W., Shi H.F., Jiang W.F., Wang X.H., Fang W.Y., Liu X. GATA4 loss-of-function mutations in familial atrial fibrillation. Clin. Chim. Acta 2011, 412:1825-1830.
51. Yang Y.Q., Li L., Wang J., Liu X.Y., Chen X.Z., Zhang W., Wang X.Z., Jiang J.Q., Liu X., Fang W.Y. A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect. Pediatr. Cardiol. 2012, 33:539-546.
52. Yang Y.Q., Gharibeh L., Li R.G., Xin Y.F., Wang J., Liu Z.M., Qiu X.B., Xu Y.J., Xu L., Qu X.K., Liu X., Fang W.Y., Huang R.T., Xue S., Nemer G. GATA4 loss-of-function mutations underlie familial tetralogy of Fallot. Hum. Mutat. 2013, 34:1662-1671.
53. Zhu W., Shiojima I., Hiroi Y., Zou Y., Akazawa H., Mizukami M., Toko H., Yazaki Y., Nagai R., Komuro I. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease. J. Biol. Chem. 2000, 275:35291-35296.